Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells

Carole Lavigne1, Alain R Thierry

  • 1Laboratoire de biologie cellulaire et de thérapie génique, Département de Biologie, Université de Moncton, 165 Massey Avenue, Moncton, New Brunswick, E1A 3E9, Canada. lavigncar@umoncton.ca

Biochimie
|July 10, 2007
PubMed

Insights

This study tracked small interfering RNAs (siRNAs) targeting cyclin D1 in breast cancer cells using a lipid-based delivery system. The siRNAs localized to unique cytoplasmic structures, showing potential for targeted gene silencing.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Lipid-based vectors are crucial for delivering small interfering RNAs (siRNAs) for gene silencing.
  • Understanding siRNA subcellular localization is key to optimizing delivery mechanisms.
  • Cyclin D1 is a significant target in breast cancer therapy.

Purpose of the Study:

  • To investigate the subcellular distribution of cyclin D1-targeting siRNAs delivered via a DLS lipid-based system in MCF-7 breast cancer cells.
  • To examine the impact of modulating cyclin D1 mRNA expression on siRNA localization and uptake.
  • To assess the efficacy and safety of the DLS system for siRNA delivery.

Main Methods:

  • MCF-7 cells were treated with cyclopentenone or 17beta-estradiol to alter cyclin D1 mRNA levels.
  • Subcellular distribution of siRNAs was qualitatively observed using microscopy.
  • Cellular uptake and cytotoxicity of lipoplexes were evaluated in the presence of serum.

Main Results:

  • siRNAs localized to distinct, granular cytoplasmic structures near the nucleus, not in early endosomes.
  • Modulating cyclin D1 expression did not alter siRNA distribution but affected cellular siRNA amounts.
  • The DLS system demonstrated low cytotoxicity and high cellular uptake, even with serum present.

Conclusions:

  • The DLS system effectively delivers siRNAs to specific cytoplasmic compartments in breast cancer cells.
  • Variations in cellular siRNA uptake may correlate with gene expression modulation.
  • The DLS system shows promise as a versatile tool for in vitro and in vivo siRNA delivery.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Regulated mRNA Transport02:22

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...